Autoren

Dr. Dieter Natlacen

Partner

Read More

Dr. Manja Epping

Partner

Read More

Evelyne Friedel

Partner

Read More

Judith Krens

Partner

Read More

Matthew Royle, Ph.D.

Partner

Read More

Verena Bertram

Salary Partner

Read More

Paul England, DPhil

Senior Professional Support Lawyer

Read More

Tasmina Goraya, PhD

Partner

Read More

Misja Boeken

Associate

Read More
Autoren

Dr. Dieter Natlacen

Partner

Read More

Dr. Manja Epping

Partner

Read More

Evelyne Friedel

Partner

Read More

Judith Krens

Partner

Read More

Matthew Royle, Ph.D.

Partner

Read More

Verena Bertram

Salary Partner

Read More

Paul England, DPhil

Senior Professional Support Lawyer

Read More

Tasmina Goraya, PhD

Partner

Read More

Misja Boeken

Associate

Read More

25. März 2019

Synapse

This month on Synapse

Bracing for Brexit – pharmaceuticals and medical devices regulation if there is "no deal"

Our European team of life sciences specialists discuss the guidance available from the European Commission, and national governments and regulatory agencies for pharmaceutical and medical devices regulation in the event of a no-deal Brexit.

Biosimilars webinar series – Recent developments in biosimilars settlements, market landscape and antitrust scrutiny

In this webinar, speakers from Taylor Wessing and Willkie Farr & Gallagher focus on key factors decision-makers need to be aware of when considering settlement.

SPC for darunavir considered invalid in Dutch preliminary relief proceedings

Judith Krens and Misja Boeken discuss a recent a request for a preliminary injunction based on the Dutch supplementary protection certificate for darunavir made to the District Court of the Hague.

Essentially biological processes and their products – what is patentable?

Paul England outlines the conflict between the EU Commission and the Enlarged Board of the EPO about whether the products of essentially biological processes are patentable.

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Synapse - law for life sciences - March 2018

15. März 2018

von Paul England, DPhil

Klicken Sie hier für Details